The Scientist

» smallpox

Most Recent

image: CDC Lab Resumes After Safety Lapses

CDC Lab Resumes After Safety Lapses

By | July 25, 2014

A high-security tuberculosis lab at the US Centers for Disease Control and Prevention may return to transferring hazardous materials.

0 Comments

image: CDC Halts Hazardous Biomaterial Transfers

CDC Halts Hazardous Biomaterial Transfers

By | July 11, 2014

A high-security tuberculosis lab at the US Centers for Disease Control and Prevention may return to transferring hazardous materials.

0 Comments

image: Smallpox Vials Found in FDA Storage

Smallpox Vials Found in FDA Storage

By | July 8, 2014

A high-security tuberculosis lab at the US Centers for Disease Control and Prevention may return to transferring hazardous materials.

0 Comments

A high-security tuberculosis lab at the US Centers for Disease Control and Prevention may return to transferring hazardous materials.

1 Comment

image: Pox Vaccine Treats Liver Cancer

Pox Vaccine Treats Liver Cancer

By | November 11, 2011

A high-security tuberculosis lab at the US Centers for Disease Control and Prevention may return to transferring hazardous materials.

0 Comments

image: A Scar Nobly Got

A Scar Nobly Got

By | July 1, 2011

A high-security tuberculosis lab at the US Centers for Disease Control and Prevention may return to transferring hazardous materials.

6 Comments

image: Book excerpt from <em>Pox: An American History</em>

Book excerpt from Pox: An American History

By | July 1, 2011

A high-security tuberculosis lab at the US Centers for Disease Control and Prevention may return to transferring hazardous materials.

0 Comments

image: WHO punts on smallpox

WHO punts on smallpox

By | May 26, 2011

A high-security tuberculosis lab at the US Centers for Disease Control and Prevention may return to transferring hazardous materials.

0 Comments

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech